PERUCCA, Simone
 Distribuzione geografica
Continente #
NA - Nord America 1.603
EU - Europa 973
AS - Asia 410
OC - Oceania 3
AF - Africa 2
SA - Sud America 2
Continente sconosciuto - Info sul continente non disponibili 1
Totale 2.994
Nazione #
US - Stati Uniti d'America 1.599
CN - Cina 298
PL - Polonia 286
UA - Ucraina 254
DE - Germania 125
IT - Italia 80
HK - Hong Kong 54
FI - Finlandia 53
GB - Regno Unito 37
SE - Svezia 36
IE - Irlanda 35
IN - India 29
FR - Francia 28
RU - Federazione Russa 15
SG - Singapore 13
DK - Danimarca 12
BE - Belgio 10
VN - Vietnam 6
TR - Turchia 5
AU - Australia 3
BO - Bolivia 2
CA - Canada 2
EG - Egitto 1
EU - Europa 1
GR - Grecia 1
IQ - Iraq 1
IR - Iran 1
JO - Giordania 1
JP - Giappone 1
KR - Corea 1
MK - Macedonia 1
MS - Montserrat 1
MX - Messico 1
ZA - Sudafrica 1
Totale 2.994
Città #
Warsaw 286
Woodbridge 202
Jacksonville 157
Fairfield 151
Houston 136
Ann Arbor 125
Ashburn 111
Cambridge 101
Chandler 101
Wilmington 88
Seattle 77
Beijing 68
Princeton 68
New York 60
Hong Kong 54
Nanjing 50
Dublin 35
Nanchang 30
Helsinki 29
Dearborn 27
Brescia 21
Tianjin 19
Shanghai 18
Jinan 15
San Diego 15
Des Moines 13
Shenyang 13
Changsha 12
Helsingør 12
Brussels 10
Hebei 9
Guangzhou 7
Hangzhou 7
Milan 7
Ningbo 7
Pune 7
San Francisco 7
Dong Ket 6
Jiaxing 6
London 5
Norwalk 5
Zhengzhou 5
Darfo 4
Kocaeli 4
Kunming 4
Nürnberg 4
Grafing 3
Haikou 3
Hefei 3
Canberra 2
Fuzhou 2
Kilburn 2
Lanzhou 2
Lappeenranta 2
Leonberg 2
Orange 2
Phoenix 2
Sucre 2
Taizhou 2
Verona 2
Amman 1
Ardabil 1
Baotou 1
Boardman 1
Bologna 1
Cairo 1
Centurion 1
Cercola 1
Chiswick 1
Chongqing 1
Dallas 1
Frankfurt am Main 1
Hanover 1
Los Angeles 1
Mexico City 1
Mumbai 1
New Delhi 1
North York 1
Porto 1
Prescot 1
Redmond 1
Rome 1
San Mateo 1
Skopje 1
Southwark 1
Strasbourg 1
Suisio 1
Sydney 1
Taiyuan 1
Tokyo 1
Toronto 1
Washington 1
Westminster 1
Wuhan 1
Yinchuan 1
Totale 2.264
Nome #
Mesenchymal stromal cells (MSCs) induce ex vivo proliferation and erythroid commitment of cord blood haematopoietic stem cells (CB-CD34+ cells) 258
BACTERIAL BLOOD STREAM INFECTIONS NEGATIVELY IMPACT ON OUTCOME OF PATIENTS TREATED WITH ALLOGENEIC STEM CELL TRANSPLANTATION: 6 YEARS SINGLE-CENTRE EXPERIENCE 225
Targeting HRASV12G Expression to the Zebrafish Early Hemogenic Progenitors Induces a Myeloproliferative Disorder by Repressing the Notch Pathway. 126
Betaherpesvirus Reactivation and Toll-Like Receptor Expression After Allogeneic Stem Cell Transplantation. 125
A specific Toll-like receptor profile on T lymphocytes and values of monocytes correlate with bacterial, fungal, and cytomegalovirus infections in the early period of allogeneic stem cell transplantation 116
TARGETING HRASV12G EXPRESSION TO THE ZEBRAFISH EARLY HEMOGENIC PROGENITORS INDUCES A MYELOPROLIFERATIVE DISORDER BY REPRESSING THE NOTCH PATHWAY. 113
Comparative study on ATG-thymoglobulin versus ATG-fresenius for the graft-versus-host disease (GVHD) prophylaxis in allogeneic stem cell transplantation from matched unrelated donor: a single-centre experience over the contemporary years 112
PARAMETERS OF PROTEIN METABOLISM AND THYROID FUNCTION AS PREDICTORS OF A SCORING SYSTEM FOR ACUTE AND CHRONIC GRAFT-VERSUS-HOST DISEASE 100
Sequential monitoring of lymphocyte subsets and of T-and-B cell neogenesis indexes to identify time-varying immunologic profiles in relation to graft-versus-host disease and relapse after allogeneic stem cell transplantation 99
Expression of Toll-Like Receptors on Peripheral Blood Cells After Allogeneic Stem Cell Transplantation: Results of a Prospective Study. 95
MULTI-GENOTYPING OF MINOR HISTOCOMPATIBILITY ANTIGENS (MHAGS) IN ALLOGENEIC STEM CELL TRANSPLANTATION AND THEIR ROLE IN DETERMINING GRAFT VERSUS HOST DISEASE (GVHD) AND GRAFT VERSUS LEUKEMIA (GVL) EFFECT. 93
A Gene Panel NGS-Based Strategy for Genomic Characterization of Acute Myeloid Leukemias (AMLs) 93
Parameters of Protein Metabolism and Thyroid Function As Predictors in a Scoring System for Acute and Chronic Graft-Versus-Host Disease 92
Acute graft-versus-host disease and expression of Toll-like receptors on peripheral blood cells after allogeneic stem cell transplantation 91
Index of Bone Marrow Output and Imbalance of B-Lymphocyte Homeostasis before and after Transplantation Correlate Differently with Graft-Versus-Host Disease and Relapse 90
WT1 Monitoring of Minimal Residual Disease (MRD) in Patients with Acute Myeloid Leukemia. 90
Parameters of Protein Metabolism and Thyroid Function As Predictors in a Scoring System for Acute and Chronic Graft-Versus-Host Disease 89
Development of a cell culture model based on biocompatible polymeric scaffolds engineered with human Mesenchymal Stromal Cells (MSCs) for cartilage and bone regenerative therapy 87
Assessment of BCR-ABL1 Transcript Levels By Digital PCR (dPCR) in CML Patients who Achieved a Deep Molecular Response (DMR: MR4.0, MR4.5 And MR5.0) with Tkis May Improve the Detection of Minimal Residual Disease (MRD) and the Selection of Patients for Treatment Free Remission (TFR) 79
Patterns of Lymphocyte Subsets and Index of Bone Marrow Output (KRECs) Correlate Differently with Graft-Versus-Host Disease and Relapse 75
A NEW PROMISING APPROACH TO PERFORM HLA TYPING IN A QUICKLY, SIMPLE AND ACCURATE WAY: THE PYROSEQUENCING 71
PYROSEQUENCING IS A NEW PROMISING APPROACH TO PERFORM HLA TYPING IN A QUICKLY, SIMPLE AND ACCURATE WAY. 70
THE PYROSEQUENCING: A NEW PROMISING APPROACH TO PERFORM HLA TYPING AND SELECT THE STEM CELL DONOR IN A QUICKLY, SIMPLE AND ACCURATE WAY 68
Digital PCR (dPCR) Overcomes the Limitations in Detection and in Quantification of Quantitative PCR (qPCR) and Reveals Different Levels of BCR-ABL1 Copies/µl Among the Chronic Myeloid Leukemia (CML) Patients Achieving Major (MR3.0) or DEEP (MR4.0, MR4.5 and MR5.0) Molecular Response with Tyrosin Kynase Inhibitors (TKIs) 68
EARLY EXTRACORPOREAL PHOTOAPHERESIS FOR THE TREATMENT OF ACUTE GRAFT VERSUS HOST DISEASE (AGVHD). 67
POST REMISSION MONITORING OF MINIMAL RESIDUAL DISEASE BY WT1 AND LEUKEMIA ASSOCIATED IMMUNOPHENOTYPE PREDICTS RELAPSE IN ACUTE MYELOID LEUKEMIA (AML) PATIENTS 65
COMBINED EFFECTS OF MESENCHYMAL STROMAL CELLS (MSC) AND STIMULATORY CYTOKINES ON THE ex vivo GROWTH OF UMBILICAL CORD BLOOD HEMATOPOIETIC PROGENITOR CELLS (UCB-HPC) 65
PROGNOSTIC RELEVANCE OF WT1 MOLECULAR LEVELS IN PATIENTS WITH ACUTE MYELOID LEUKEMIA AFTER ALLOGENEIC STEM CELL TRANSPLANTATION. 63
EXTRACORPOREAL PHOTOPHERESIS (ECP) FOR TREATEMENT OF ACUTE AND CHRONIC GRAFT VERSUS HOST DISEASE: AN ITALIAN MULTICENTRIC RETROSPECTIVE ANALYSIS ON 94 PATIENTS ON BEHALF OF THE GRUPPO ITALIANO TRAPIANTO DI MIDOLLO OSSEO (GITMO) 62
Comparative Study on Fresenius-ATG Versus Thymoglobuline-ATG for the Graft Versus Host Disease (GVHD) Prophylaxis in Allogeneic Stem Cell Transplantation from Matched Unrelated Donor: A Single Center Experience on 76 Patients 62
MULTI-GENOTYPE OF MINOR HISTOCOMPATIBILITY ANTIGENS (MHAGS) TO STUDY GRAFT VERSUS HOST DISEASE (GVHD) AND GRAFT VERSUS LEUKEMIA (GVL) EFFECTS IN ALLOGENEIC STEM CELL TRANSPLANTATION. 61
Digital PCR (Dpcr) a Step Forward to Detection and Quantification of Minimal Residual Disease (MRD) in Ph+/BCR-ABL1 Chronic Myeloid Leukemia (CML) 59
PROFILE OF TOLL-LIKE RECEPTORS ON MONOCYTES AND LYMPHOCYTES IN RELATION TO INFECTIOUS COMPLICATIONS AND OUTCOME IN ALLOGENEIC STEM CELL TRANSPLANTATION. 56
Safety and Efficacy of ATG-based GvHD prophylaxis in allogeneic stem cell transplantation for acute leukemia and myelodysplastic syndrome: a single center experience 55
Totale 3.140
Categoria #
all - tutte 11.343
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 11.343


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/201974 0 0 0 0 0 0 0 0 0 0 26 48
2019/2020811 93 17 18 67 45 87 102 86 79 128 36 53
2020/2021549 13 55 12 63 20 60 24 73 53 92 64 20
2021/2022302 19 38 1 19 16 28 19 14 12 49 18 69
2022/2023277 46 8 10 20 26 60 2 32 52 3 7 11
2023/2024307 29 10 34 15 16 96 20 25 60 2 0 0
Totale 3.140